Pfizer didn’t sell any cancer treatments 20 years ago. Now, it sells 17, including four that were approved in the U.S. at the end of last year.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Blood pressure medication recall over cancer risk expanded for more losartan drugsTorrent Pharmaceuticals said six more lots of losartan potassium and hydrochlorothiazide tablets contain trace amounts of a probable human carcinogen.
Baca lebih lajut »
FDA: Blood pressure drug carcinogens went undetected for four years, cancer risk smallThe FDA said blood pressure drug impurities stemmed from a manufacturing change. The factories that make these drugs are subject to new testing standards
Baca lebih lajut »
Market Volatility Tests UBS’s Pivot to the UltrarichSwiss bank UBS said it swung to a profit in the fourth quarter but missed analysts’ expectations, as volatile financial markets weighed on its wealth-management unit.
Baca lebih lajut »
A top Novartis executive says the $225 billion drug giant is planning for a 'doomsday scenario' in cancer treatmentPharma giant Novartis is developing drugs that could prevent cancer before patients get it. One big question: how will we pay for them?
Baca lebih lajut »